2026 Healthcare M&A: What’s Changed, What’s Working, And Where Deals Are Moving

Key Takeaways – Healthcare M&A activity is rebounding in 2026, but with higher execution standards. Capital is returning to the market, particularly in the middle market, but investors are prioritizing proven operating models, durable reimbursement, and realistic paths to margin improvement over growth narratives alone….
By: Arnall Golden Gregory LLP